Clinical Trial Update: Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) [EARLY_Phase 1]

View source ↗

Summary

The PLIGHT trial, studying phototherapy combined with mogamulizumab in early-stage mycosis fungoides, has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides

Drugs mentioned

• Mogamulizumab (Poteligeo) (mogamulizumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Mycosis Fungoides | EARLY_Phase 1 | Status: SUSPENDED